The size of the North America Surgical Sealants and Adhesives Market was worth USD 896.81 million in 2022. It is estimated to grow at a CAGR of 9.5% and grow USD 1411.79 million by 2027. It is the largest regional market worldwide, capturing a market share of 40%.
The increasing use of technologically advanced products, the growing need for effective management of blood loss in patients and the increase in the number of surgeries worldwide are some of the factors that are expected to drive the growth of the Surgical Adhesives and Sealants Market over the forecast period 2020-2027. . On the other hand, the increasing importance of adhesive dentistry and improving healthcare systems in developing regions will create more opportunities leading to the growth of the surgical adhesives and sealants market during the aforementioned period.
Rising healthcare costs and tight reimbursements will constrain the growth of the surgical adhesives and sealants market during the aforementioned period. The development of new biomaterials will challenge the growth of the surgical adhesives and sealants market.
The market is driven by the increasing prevalence and incidence rates of various disorders such as obesity and cardiovascular disease; increased incidence of trauma; the growth in the number of sports-related accidents and injuries, which has led to an increase in surgeries performed around the world. In addition, the need to control blood loss in patients to bring innovative products to market is contributing to the growth of the market.
Unfavorable reimbursement policies for various surgeries and the availability of alternative options which tend to be much more compliant and effective have held back the growth of this market.
The increase in cosmetic surgery procedures is also increasing the adoption of surgical sealants and adhesives in cosmetic procedures around the world.
The pandemic has had ramifications in the working methods for various surgeries. There are strict specialty-specific guidelines that must be implemented and followed so that surgeons can continue to provide safe and effective care to their patients during the COVID-19 pandemic. The volume of surgeries declined dramatically during the pandemic, due to strict guidelines from regulatory authorities to avoid all elective surgeries. This will impact the supply of surgical adhesives and sealants to hospitals and medical centers.
This research report on the North America Surgical Sealants and Adhesives Market has been segmented and sub-segmented into the following categories:
The United States dominates the North America surgical adhesives and sealants market and the US surgical adhesives and sealants market is expected to experience the highest CAGR during the forecast period. Factors such as growing investments by major players in these regions, increased health awareness, increased per capita income, increased medical tourism, presence of less stringent regulations and growing demand for healthcare are expected to drive to the growth of this market during the forecast period.
According to the Association for the Advancement of Medical Instrumentation, the number of ambulatory surgery centers (ASCs) in the United States is increasing. The number of CHWs in the United States has almost doubled, from 5,270 centers in 2017 to 9,290 in 2019. In addition, the prevalence of several disorders associated with surgery is also increasing in this region. For example, the United States recorded 3,462,600 new cases of osteoid arthritis in 2019. While the prevalence of gynecological diseases was 23,764,700 cases in 2019, this increasing prevalence of various diseases is therefore expected to have a positive impact on growth over the forecast period.
KEY MARKET PLAYERS:
Some of the notable companies operating in the North America surgical sealants and adhesives market profiled in the report are CryoLife, Inc, Johnson & Johnson, Ethicon, Inc., Baxter International, Inc, and C.R. Bard, Inc, Cohera Medical, Inc. Ocular Therapuetix, Inc, Vivostat A/S and Sealants Ltd, Medtronic plc, Sanofi Group, B. Braun Melsungen AG.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com